Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumours

Anticancer Research

Volumn 22, Issue 2 A, 2002, Pages 707-711

  Holwell, S E ^a   Cooper, P A ^a   Grosios, K ^a   Lippert III, J W ^a   Pettit, G R ^a   Shnyder, S D ^a   Bibby, M C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Colon tumours; Combretastatin A 1 phosphate; Haemorrhagic necrosis

Indexed keywords

ANTINEOPLASTIC AGENT; COMBRETASTATIN A1 PHOSPHATE; COMBRETASTATIN A4; TUBULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON TUMOR; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; DRUG TOLERABILITY; FEMALE; HISTOLOGY; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; FEMALE; MICE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATES; PRODRUGS; STILBENES; TUBULIN;

EID: 0036253091     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Isolation, structure and synthesis of combretastatins A1 and B1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum
2. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A4
3. Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile
4. Antineoplastic agents 322. Synthesis of combretastatin A4 prodrugs
5. Combretastatin A4, an agent that displays potent and selective toxicity towards tumour vasculature
6. In vivo and in vitro evaluation of combretastatin A4 and its sodium phosphate prodrug
7. Phase I/Pharmacokinetic trial of the endothelial toxin combretastatin A4P (CA4P) administered as an IV bolus on a daily × 5 schedule every 21 days
8. Combretastatin A4 phosphate targets vasculature in animal and human tumours
9. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs
10. UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia
11. Transplantation of adenocarcinomas of the colon in mice
12. Combination chemotherapy with combretastatin A4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinoma
13. Protocols for screening chemical agents and natural products against tumours and other biological systems
14. Validation of the fluorescent dye Hoechst 33342 as vascular space marker for tumours
15. Characterisation of the vasculature within a murine adenocarcinoma growing in different sites to evaluate the potential of vascular therapies
16. Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid
17. Effects of novel and conventional anti-cancer agents on human endothelial permeability: Influence of tumour secreted factors
18. Anti-vascular approaches to solid tumour therapy: Evaluation of combretastatin A4 phosphate